在常见的可变免疫缺陷障碍中的门高血压 - - 196名患者的临床和免疫学参数单一中心分析

Leif G Hanitsch1,2, Sophie Steiner1, Michael Schumann3

  • 1Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.

Frontiers in immunology
|January 8, 2024
PubMed
概括

门性高血压 (PH) 影响5.6%的常见变性免疫缺陷 (CVID) 患者,增加死亡率. 早期检测可能涉及监测腹巨变,GGT,sIL-2R和血小板水平.